About CLINUVEL

Contact

Head Office

CLINUVEL PHARMACEUTICALS LIMITED,
Level 6,
15 Queen Street,
Melbourne
Victoria 3000
Australia

Tel: +61 3 9660 4900
Fax: +61 3 9660 4909
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

UK office

Wesley House,
Bull Hill
Leatherhead, KT22 7AH
United Kingdom

Tel: +44 1372 860 765

Singapore office

9 Temasek Blvd #29-01
Singapore 038989

US Office

PO BOX 7388,
Menlo Park, CA 94026

Tel: +1 372 860 765

Swiss Office

Zugerstrasse 76a,
6340 Baar,
Switzerland

Tel: +41 41 763 1782
Fax: +41 41 763 1784
 

 

 

CLINUVEL receives a large number of inquiries every day. For a list of frequently asked questions, please click here.

For more information on CLINUVEL’s program for SCENESSE® in EPP, please go to the following page.

For more information on CLINUVEL’s program for SCENESSE® in Vitiligo, please go to the following page.

If you have any additional questions, you can send us a message by filling out this online form.
If you have any investor related questions, you can send us a message by filling out this online form.
If you experience any side effects while using a CLINUVEL product, please feel free to contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

Latest Company Announcements

12 April 2017

Lapse and Forfeit of Unlisted Conditional Performance Rights

Lapse and Forfeit of Unlisted Conditional Performance Rights

Read More
12 April 2017

CLINUVEL reaches agreement on German SCENESSE® pricing through AMNOG Arbitration Board

CLINUVEL reaches agreement on German SCENESSE® pricing through AMNOG Arbitration Board

Read More
31 January 2017

Appendix 4C - Quarterly report

Quarterly report

Read More
23 December 2016

Appendix 3Y

Change of Director’s Interest Notice

Read More

Quick Links